All about preclinical and clinical trial requirements in Russia. Prepared in association with Lidings, a leading global law firm, this is an extract…

An intro to the legal situation for regulatory, pricing and reimbursement in Russia. Prepared in association with Lidings, a leading global law firm,…

Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the…

The latest Russia Pharma News, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing, Geropharm’s deal to produce insulin in…

The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…

Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally.…

Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates,…

The year 2019, which continued the trend of rapid and numerous changes in healthcare regulations in Russia, was rich with expectations, events and…

The top 10 pharmaceutical companies in the Russian hospital market for the nine months up to November 2019, sorted by percentage share of total…

Nadezhda Fedotova and Andrey Zelenin of Lidings law firm gives an update on recent amendments to the labeling legislation for medicines in Russia,…

Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of…

Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater responsibilities in the Middle…